SecBot SecBot
SECBOTREPLAY Home › Report › ARWR

ARWR · Two directors at Arrowhead Pharmaceuticals sold a combined $1.19M in…

ARROWHEAD PHARMACEUTICALS, INC. · CLUSTER filed Aug 20, 2026 at 17:25 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 20, 2026 at 17:25 ET

Two directors at Arrowhead Pharmaceuticals sold a combined $1.19M in open-market sales on August 18, 2026. This is a small cluster relative to the $12.6B market cap (0.009%), and both sellers are directors, not C-suite executives, which per academic literature makes cluster sales a weak signal. The sales are likely liquidity-driven and do not indicate a material bearish view on the company's prospects.

  • Two directors sold shares on the same day: Michael S. Perry sold 11,600 shares at $87.30 ($1.01M), and Adeoye Y. Olukotun sold 2,000 shares at $86.96 ($174K).
  • Total open-market sales of $1.19M represent only 0.009% of ARWR's $12.6B market cap, well below the 0.1% threshold for materiality.
  • Both sellers are directors, not C-suite executives; insider sales by directors are less informative than sales by the CEO or CFO.
  • No 10b5-1 plan or pattern information is available, but the small size and director status suggest routine portfolio diversification.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access